Skip to main content

Starling Oncology, Inc.

For the period ended Dec 31, 2024. Filed Mar 26, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 26, 2025

STLN$4.00+10.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned hereunto duly authorized, on this the 25th day of March, 2025.

THE ONCOLOGY INSTITUTE, INC.
By:/s/ Robert Carter
Robert Carter
Chief Financial Officer(Duly Authorized Officer)

SIGNATURES AND POWER OF ATTORNEY

We, the undersigned officers and directors of The Oncology Institute, Inc., hereby severally constitute and appoint Daniel Virnich and Robert Carter, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities held on the dates indicated.

SignatureTitleDate
/s/ Daniel Virnich
Daniel VirnichChief Executive Officer and Director(Principal Executive Officer)March 25, 2025
/s/ Robert Carter
Robert CarterChief Financial Officer (Principal Financial and Accounting Officer)March 25, 2025
/s/ Richard Barasch
Richard BaraschDirectorMarch 25, 2025
/s/ Karen Johnson
Karen JohnsonDirectorMarch 25, 2025
/s/ Mohit Kaushal
Mohit KaushalDirectorMarch 25, 2025
/s/ Gabriel Ling
Gabriel LingDirectorMarch 25, 2025
/s/ Anne McGeorge
Anne McGeorgeDirectorMarch 25, 2025
/s/ Mark Pacala
Mark PacalaDirectorMarch 25, 2025
SignatureTitleDate
/s/ Brad Hively
Brad HivelyDirectorMarch 25, 2025
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.